Literature DB >> 18638303

Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure.

John F Patzer1.   

Abstract

New detoxification modes of treatment for liver failure that use solid adsorbents to remove toxins bound to albumin in the patient bloodstream are entering clinical evaluations, frequently in head-to-head competition. While generally effective in reducing toxin concentration beyond that obtainable by conventional dialysis procedures, the solid adsorbent processes are largely the result of heuristic development. Understanding the principles and limitations inherent in competitive toxin binding, albumin versus solid adsorbent, will enhance the design process and, possibly, improve detoxification performance. An equilibrium thermodynamic analysis is presented for both the molecular adsorbent recirculating system (MARS) and fractionated plasma separation, adsorption, and dialysis system (Prometheus), two advanced systems with distinctly different operating modes but with similar equilibrium limitations. The Prometheus analysis also applies to two newer approaches: sorbent suspension reactor and microsphere-based detoxification system. Primary results from the thermodynamic analysis are that: (i) the solute-albumin binding constant is of minor importance to equilibrium once it exceeds about 10(5) L/mol; (ii) the Prometheus approach requires larger solid adsorbent columns than calculated by adsorbent solute capacity alone; and (iii) the albumin-containing recycle stream in the MARS approach is a major reservoir of removed toxin. A survey of published results indicates that MARS is operating under mass transfer control dictated by solute-albumin equilibrium in the recycle stream, and Prometheus is approaching equilibrium limits under current clinical protocols.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18638303      PMCID: PMC2562354          DOI: 10.1111/j.1525-1594.2008.00581.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  28 in total

Review 1.  Emerging indications for albumin dialysis.

Authors:  Sambit Sen; Roger Williams; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

2.  In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation.

Authors:  Peter Krisper; Bernd Haditsch; Rudolf Stauber; Aleksandra Jung; Vanessa Stadlbauer; Michael Trauner; Herwig Holzer; Daniel Schneditz
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

3.  Slow continuous ultrafiltration with bound solute dialysis.

Authors:  John F Patzer; Stefan A Safta; Richard H Miller
Journal:  ASAIO J       Date:  2006 Jan-Feb       Impact factor: 2.872

4.  The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure.

Authors:  C Di Campli; M A Zocco; R Gaspari; M Novi; M Candelli; A Santoliquido; R Flore; P Tondi; R Proietti; G Gasbarrini; P Pola; A Gasbarrini
Journal:  Transplant Proc       Date:  2005 Jul-Aug       Impact factor: 1.066

5.  Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT.

Authors:  A J Ellis; R D Hughes; D Nicholl; P G Langley; J A Wendon; J G O'Grady; R Williams
Journal:  Int J Artif Organs       Date:  1999-01       Impact factor: 1.595

6.  The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results.

Authors:  A Skwarek; M Grodzicki; P Nyckowski; M Kotulski; K Zieniewicz; B Michalowicz; W Patkowski; I Grzelak; A Paczkowska; D Giercuszkiewicz; J Sańko-Resmer; L Paczek; M Krawczyk
Journal:  Transplant Proc       Date:  2006 Jan-Feb       Impact factor: 1.066

Review 7.  Fulminant hepatic failure.

Authors:  A O Shakil; G V Mazariegos; D J Kramer
Journal:  Surg Clin North Am       Date:  1999-02       Impact factor: 2.741

8.  Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure.

Authors:  Pieter Evenepoel; Wim Laleman; Alexander Wilmer; Kathleen Claes; Bart Maes; Dirk Kuypers; Bert Bammens; Frederik Nevens; Yves Vanrenterghem
Journal:  Blood Purif       Date:  2005-07-11       Impact factor: 2.614

9.  Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.

Authors:  Lakhmir S Chawla; Florin Georgescu; Bruce Abell; Michael G Seneff; Paul L Kimmel
Journal:  Am J Kidney Dis       Date:  2005-03       Impact factor: 8.860

10.  Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.

Authors:  Vanessa Stadlbauer; Peter Krisper; Ulrich Beuers; Bernd Haditsch; Daniel Schneditz; Aleksandra Jung; Csilla Putz-Bankuti; Herwig Holzer; Michael Trauner; Rudolf E Stauber
Journal:  ASAIO J       Date:  2007 Mar-Apr       Impact factor: 2.872

View more
  3 in total

Review 1.  Extracorporeal liver support.

Authors:  Jan Stange
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

2.  Proteomic analysis of polypeptides captured from blood during extracorporeal albumin dialysis in patients with cholestasis and resistant pruritus.

Authors:  Marina Gay; Albert Pares; Montserrat Carrascal; Pau Bosch-i-Crespo; Marina Gorga; Antoni Mas; Joaquin Abian
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

3.  Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy.

Authors:  Griet Glorieux; James Tattersall
Journal:  Clin Kidney J       Date:  2015-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.